These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Intermittent atrial fibrillation may account for a large proportion of otherwise cryptogenic stroke: a study of 30-day cardiac event monitors. Elijovich L; Josephson SA; Fung GL; Smith WS J Stroke Cerebrovasc Dis; 2009; 18(3):185-9. PubMed ID: 19426887 [TBL] [Abstract][Full Text] [Related]
43. [Reasons for underuse of oral anticoagulation in atrial fibrillation-associated stroke: prospective study of German stroke patients]. Reicke B; Masuhr F; Weih M Fortschr Neurol Psychiatr; 2008 Jul; 76(7):391-5. PubMed ID: 18604772 [TBL] [Abstract][Full Text] [Related]
44. Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis. Andersen LV; Vestergaard P; Deichgraeber P; Lindholt JS; Mortensen LS; Frost L Heart; 2008 Dec; 94(12):1607-13. PubMed ID: 18208828 [TBL] [Abstract][Full Text] [Related]
45. Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures. Bunch TJ; Crandall BG; Weiss JP; May HT; Bair TL; Osborn JS; Anderson JL; Lappe DL; Muhlestein JB; Nelson J; Allison S; Foley T; Anderson L; Day JD J Cardiovasc Electrophysiol; 2009 Sep; 20(9):988-93. PubMed ID: 19473299 [TBL] [Abstract][Full Text] [Related]
46. Subclinical atrial fibrillation: how hard should we look? Wachter R; Stahrenberg R; Gröschel K Heart; 2013 Feb; 99(3):151-3. PubMed ID: 23010289 [No Abstract] [Full Text] [Related]
47. Strategies for primary and secondary stroke prevention in atrial fibrillation. Finsterer J; Stöllberger C Neth J Med; 2008 Sep; 66(8):327-33. PubMed ID: 18809979 [TBL] [Abstract][Full Text] [Related]
48. Approach to management of the patient over age 75 with atrial fibrillation. Michelena HI; Ezekowitz MD Cardiol Rev; 2000; 8(1):9-16. PubMed ID: 11174869 [TBL] [Abstract][Full Text] [Related]
51. Insights from the RCPE UK Consensus Conference on approaching the comprehensive management of atrial fibrillation. Lip GY; Ramsay SG Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):697-700. PubMed ID: 22894625 [TBL] [Abstract][Full Text] [Related]
52. Atrial fibrillation. Harv Mens Health Watch; 1998 Apr; 2(9):1-4. PubMed ID: 9537111 [No Abstract] [Full Text] [Related]
53. Overview of the management of atrial fibrillation: what is the current state of the art? Kowey PR; Yan GX; Dimino TL; Kocovic DZ J Cardiovasc Electrophysiol; 2003 Dec; 14(12 Suppl):S275-80; discussion S280. PubMed ID: 15005214 [TBL] [Abstract][Full Text] [Related]
54. Alternatives to warfarin in atrial fibrillation: drugs and devices. Bayard YL; Ostermayer SH; Sievert H Heart; 2008 Sep; 94(9):1113-6. PubMed ID: 18703688 [No Abstract] [Full Text] [Related]
55. Approach to AF in older adults on target. Aronow WS Geriatrics; 2007 Mar; 62(3):11. PubMed ID: 17346093 [No Abstract] [Full Text] [Related]
57. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment. Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D Thromb Haemost; 2009 May; 101(5):938-42. PubMed ID: 19404548 [TBL] [Abstract][Full Text] [Related]
58. Sustainability and impact of warfarin compliance for atrial fibrillation. Kuo S; Burrill J Med Health R I; 2007 Dec; 90(12):378-80. PubMed ID: 18314828 [No Abstract] [Full Text] [Related]
59. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer]. Mooe T Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861 [No Abstract] [Full Text] [Related]
60. [Anticoagulants to more people can prevent many cases of stroke]. Friberg L; Rosenqvist M Lakartidningen; 2015 Sep; 112():. PubMed ID: 26348045 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]